/ EN

Dimiter S. Dimitrov, Ph.D.

***** Dr. Dimiter Dimitrov is Director of Center for Antibody Therapeutics at Department of Medicine at University of Pittsburg. He obtained his Ph.D. in chemistry at the University of Sofia, and his Sc.D. in biology at the Bulgarian Academy of Sciences, where he was elected as a Professor of Biophysics. He was appointed to the Senior Biomedical Research Service at NIH and selected as an NCI outstanding mentor. He published over 400 peer reviewed articles and book chapters. He is the inventor of over 100 patents. His research focuses on development of human monoclonal antibodies including isolated engineered antibody domains for prevention and treatment of cancer and other diseases. Dr. Dimitrov and his research group are experts in display/screening/libraries methodologies, antibody engineering, and protein biochemistry, structural biology and computational biology as well as virology, immunology and cancer biology.

John W. Mellors, M.D

***** Dr. John Mellors is a Professor of Infectious Diseases and Microbiology, University of Pittsburgh Medical Center (UPMC), Endowed Chair at Glo

Scott M. Whitcup, M.D.

***** Dr. Scott Whitcup is the Founder and CEO of Akrivista. Previously, he was Chief Scientific Officer at Allergan, and served on the Board of Semnur Pharmaceuticals, Nightstar Therapeutics, Avanir Pharmaceuticals, and Questcor Pharmaceuticals. He has expertise in ophthalmology, CNS, urology, dermatology, medical aesthetics, anti-infectives, and obesity. He published over 200 peer reviewed articles and 150 patents. Dr. Whitcup holds a B.A. in Neurobiology and Behavior from Cornell University and an M.D. from Cornell University Medical College. He has completed a residency in Internal Medicine at UCLA, a residency in Ophthalmology at Harvard Medical School-Massachusetts Eye & Ear Infirmary and a fellowship in Uveitis and Ocular Immunology at the National Eye Institute, National Institutes of Health. He is a Diplomate of both the American Board of Institute, David Geffen School of Medicine at the University of California at Los Angeles. Dr. Whitcup also worked in leadership positions at the National Eye Institute at NIH.

Lai Wei, Ph.D.

Scientific Founder in Ophthalmology

***** Prof. Lai Wei received his Ph.D. in Bioinformatics and Pathology from University of Tennessee Health Science Center in 2006. He then worked as a Research Fellow, Staff Scientist, and Principal Investigator in National Institutes of Health, USA. He became a Professor of Ophthalmology in Zhongshan Ophthalmic Center, Sun Yat-sen University in Guangzhou China in 2013. Prof. Wei’s work combines wet and dry lab tools to study the etiology and therapies of ocular inflammatory diseases. He has published more than 90 peer reviewed papers in journals, including Nature, Nature Immunology, Immunity, and Cancer Cell et al. (total citations > 8400).

Xuebin Liao, Ph.D.

Scientific Founder in immunotherapy

***** Xuebin Liao obtained his B.S. degree from Peking University in 1995. Then he did his Ph.D work on natural product synthesis with Prof. James M. Cook at the University of Wisconsin at Milwaukee from 1998-2004. After that, from 2005-2008, he was a postdoctoral associate with Prof. John F. Hartwig at Yale and later at UIUC. In 2009, he held a position of Research Investigator at GNF (the Genomics Institute of the Novartis Research Foundation). In September of 2012, he joined the Department of Pharmacology and Pharmaceutical Science, School of Medicine, Tsinghua University. Now Liao is a Professor in the School of Pharmaceutical Science, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University, where his researches focuses on three major areas: (1) bioactive natural-product-oriented synthesis and the development of new synthetic methods, (2) immuno-oncology projects related to T-cell exhaustion and innate immunity, and (3) structure-based drug discovery. He published over 50 peer reviewed papers in journals, Including Nature, Cancer Cell, Science Translational Medicine, JACS, Science Advance, Angew Chem Int Ed et al.

Rongsheng Jin, Ph.D.

Scientific Founder in Medical Aesthetics

***** Dr. Rongsheng Jin is a Professor in the Department of Physiology and Biophysics at University of California, Irvine. Dr. Jin earned his M.S. degree from Institute of Biophysics (Chinese Academy of Sciences) and Ph.D. degree from Columbia University. He then carried out postdoctoral research at Stanford University and Howard Hughes Medical Institute (HHMI). Dr. Jin was a recipient of the Alfred P. Sloan Research Fellowship in 2009 and the Young Investigators Grant from the Human Frontier Science Program in 2011. Dr. Jin is a leader in mechanistic and structural studies of botulinum neurotoxins (BoNTs) with international reputation and collaborator worldwide, who has published extensively on bacterial toxins in high profile journals. Some of his seminal works on BoNTs include the crystal structures of BoNT/A and BoNT/B in complex with their neuronal receptors, as well as the first structure of a large BoNT/A multi-protein complex, which is the active pharmaceutical ingredient in the commercial BoNT/A products on the market. These studies provide the structural basis for protein engineering of BoNTs for improved therapeutic and cosmetic applications.

Min Jin, M.D.

Scientific Founder in Modern Traditional Chinese Medicine

***** Dr. Min Jin is the Chief Physician in the Department of Ophthalmology, China-Japan Friendship Hospital, Beijing and a professor of Ophthalmology at Beijing University of Chinese Medicine. She received a bachelor's degree from Beijing University of Chinese Medicine in 1982 and a master's degree in ophthalmology from Peking Union Medical College in 1999. As a leading Ophthalmologist practicing both Traditional Chinese Medicine and western medicine, Dr. Jin is the current or the honorary presidents of several Chinese Ophthalmologist Societies. Prof. Jin has published more than 110 peer reviewed papers. She specializes in ophthalmic diseases, including age-related macular degeneration (AMD) and dry eye. She won many awards including the "Beijing Chinese Medicine Ophthalmology Center Award", "Academic Leader Award", and “Chinese Medicine Life Time Achievement Award”.

Mingguo Huang

Chairman of the Board

***** Mr. Mingguo Huang received his Bachelor of Science degree from Peking University and attended the Advanced Management Program at Harvard University. He has more than 20 years of experiences in entrepreneurship, management, and investment. As a serial entrepreneur, Mr. Huang successfully founded and managed multiple startup companies.
Previous page

Home   丨   About Us   丨   Product and Pipeline   丨   Our Team   丨   News   丨   Career   丨   Contact

Address: 106 Fengze East Road, Nansha District, Guangzhou 
Email: ming-med@ming-med.com

Copyright © 2020 ming-med.com  保留所有权利  粤ICP备20029450号-1